Thiamine in Aluminium Phosphide Poisoning

The Effect of Thiamine in Aluminium Phosphide Poisoning Patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211221053473N1

Enrollment

Registered

2021-12-26

Start date

2021-01-01

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aluminium Phosphide Poisoning.

Interventions

Intervention group: Two Groups of Patients are Selected Randomly

the Ones who Receive 300 mg Thiamine produced by Mongel Co. by Injection and the Others who Don't. A Satisfaction Form is Filled by the Patient or their Relatives on Arrival..

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The Use of Alminium Phosphide in any Dose

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
In all the Patients, the Sign & Symptoms Including Vomit, Abdominal Pain, Tachycardia, Sweating, Tachypnea, Metabolic Acidosis, Hypotension, Poisoning Sequela, EF, Renal Failure, Clinical Markers, Bi-Carbonate Injection, Dosage of AlP, Manner of Poisoning and Mortality Rate are Studied. Timepoint: All the Mentioned Parameters are Measured on Arrival of the Patient to the Hospital. Method of measurement: All the Mentioned Parameters are Measured by Blood Tests and Examination.	—

Measure

Time frame

In all the Patients, the Sign & Symptoms Including Vomit, Abdominal Pain, Tachycardia, Sweating, Tachypnea, Metabolic Acidosis, Hypotension, Poisoning Sequela, EF, Renal Failure, Clinical Markers, Bi-Carbonate Injection, Dosage of AlP, Manner of Poisoning and Mortality Rate are Studied. Timepoint: All the Mentioned Parameters are Measured on Arrival of the Patient to the Hospital. Method of measurement: All the Mentioned Parameters are Measured by Blood Tests and Examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaral Dehghanpisheh

Tehran University of Medical Sciences

dr.dehghanpisheh@gmail.com+98 71 3626 6308

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026